Karri A. Bauer
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Antibiotic Use and Resistance, Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing, Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus
Most-Cited Works
- → An Antimicrobial Stewardship Program’s Impact with Rapid Polymerase Chain Reaction Methicillin‐ResistantStaphylococcus aureus/S. aureusBlood Culture Test in Patients withS. aureusBacteremia(2010)341 cited
- → Review of Rapid Diagnostic Tests Used by Antimicrobial Stewardship Programs(2014)253 cited
- → Antimicrobial stewardship across 47 South African hospitals: an implementation study(2016)210 cited
- → Extended-Infusion Cefepime Reduces Mortality in Patients with Pseudomonas aeruginosa Infections(2013)152 cited
- → Mortality Among US Patients Hospitalized With SARS-CoV-2 Infection in 2020(2021)151 cited
- → Is the "Low-Hanging Fruit" Worth Picking for Antimicrobial Stewardship Programs?(2012)106 cited
- → Point-of-care testing for infectious diseases: Opportunities, barriers, and considerations in community pharmacy(2014)97 cited
- → A Stewardship Program’s Retrospective Evaluation of Vancomycin AUC24/MIC and Time to Microbiological Clearance in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis(2013)75 cited
- → Eight Habits of Highly Effective Antimicrobial Stewardship Programs to Meet the Joint Commission Standards for Hospitals(2017)75 cited
- → Antimicrobial stewardship and antibiograms: importance of moving beyond traditional antibiograms(2021)73 cited